ACELYRIN, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
SLRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
4149 Liberty Canyon Rd., Agoura Hills, CA

Insiders trading volume in the past year

ACELYRIN, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Westlake BioPartners Fund II, L.P. 10%+ Owner $72.5M May 9, 2023
Shao-Lee Lin Chief Executive Officer, Director $10.5M -$265K -2.46% Apr 1, 2024
Paul Peloso Chief Medical Officer $1.19M Oct 4, 2023
Ronald Oyston Chief People Officer $1.05M Jan 9, 2024
Melanie Gloria Chief Operating Officer $582K May 23, 2024
Mina Kim Chief Executive Officer, Director $495K May 26, 2024
Gil M. Labrucherie CFO and CBO $348K Aug 31, 2024
Sanam Pangali CLO & Head of People $331K May 23, 2024
Patrick Machado Director $109K Jun 7, 2024
Mardi Dier CFO and CBO $47.6K May 9, 2023
Daniel J. Becker Director $20.6K -$7 -0.03% Jul 17, 2024
Amar Murugan Chief Legal Officer $3.43K Nov 25, 2024
Bruce C. Cozadd Director Jun 7, 2024
Dawn Svoronos Director Jun 7, 2024
Shephard Mpofu Chief Medical Officer May 23, 2024
Henry O. Gosebruch Director Jun 7, 2024
Lynn A. Tetrault Director Jun 7, 2024
AyurMaya Capital Management Company, LP Director, Other* May 9, 2023
Beth C. Seidenberg Director Jun 7, 2024
Alan Colowick Director May 4, 2023

Recent Insider Transactions by Companies or Individuals for ACELYRIN, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.